Skip to content

Muscular Electrical Stimulation after Cardiac Surgery

Neuromuscular Electrostimulation in the Postoperative of Cardiac Surgery: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8vkw87
Enrollment
Unknown
Registered
2016-07-05
Start date
2014-01-21
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease, thoracic surgery, muscle weakness, cardiovascular deconditioning

Interventions

- Control Groups 42 patients (21 after valve replacement surgery and 21 postoperative coronary artery bypass graft) will be subjected to conventional physical therapy protocol performed by hospital p
. Araújo et al, 2012). The intensity will be adjusted to the visible muscle contraction and in the case of doubt the contraction will be confirmed by palpation of the involved muscles (ROUTSI et al.,
Device
Q65.060

Sponsors

Universidade Federal de Sergipe
Lead Sponsor
Fundação de Beneficência Hospital de Cirurgia
Collaborator

Eligibility

Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Will be included in the study cardiac patients of both sexes; aged between 18 and 75 years old who are hospitalized for surgical treatment of Myocardial Revascularization and Valve exchange; being allocated to different groups.

Exclusion criteria

Exclusion criteria: Patients with some type of psychiatric condition; cognitive decline or dementia that could influence the communication process; the presence of musculoskeletal disorder or neuromuscular recent or unresolved that limits or precludes the ability to walk; mobility or functional capacity; hemodynamic instability (Mean Arterial Pressure 120 mm Hg); dyspnea with oxygen saturation less than 90%; tachycardia or bradycardia; cardiac pacemaker carriers; individuals with dermatitis; damaged skin and sensitivity changes that preclude the application of NMES will be deleted from study.

Design outcomes

Primary

MeasureTime frame
Increase in the average distance walked in the experimental group compared to the control group checked by the 6-minute walking test (6MWT) from the realization of a range of at least 30 meters between the groups.

Secondary

MeasureTime frame
- Reducing the blood lactate response to exercise in the experimental group compared to the control group checked by lactimetria from the finding of a significant statistical variation between groups with 5% significance level. - Improves muscle strength for knee extension verified by digital dynamometer from the finding of a significant statistical variation between groups with 5% significance level. - Improves muscle strength to hand grip verified by dynamometer from the realization of a significant statistical variation between groups with 5% significance level. - Improved overall muscle strength verified by the MRC scale (Medical Research Council) from the finding of a significant statistical variation between groups with 5% significance level. - Improved electrical activity of the rectus femoris muscle, verified by analysis of surface electromyography signal from the finding of a significant statistical variation in RMS variable (room mean square) between groups with 5% significance level. - Improved functionality verified by total score and motor fields in the questionnaire and cognitive FIM (Functional Independence Measure) from the finding of a significant statistical variation between groups with 5% significance level. - Improved quality of life questionnaire verified by NHP (Nottingham Health Profile) from finding statistically significant difference (p 20%, arrhythmias and changes> 4-5% in SpO2.

Countries

Brazil

Contacts

Public ContactManoel;Telma Cerqueira Neto;Cerqueira

Universidade Federal de Sergipe;Universidade Federal de Sergipe

mlcerqueiraneto@gmail.com;telmac@gmail.com557932175928;557932175928

Outcome results

None listed

Source: REBEC (via WHO ICTRP)